The classic website will no longer be available as of June 25, 2024. Please use the modernized
Working… Menu

Safety and Tolerability Subretinal OPGx-001 for LCA5-Associated Inherited Retinal Degeneration (LCA5-IRD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT05616793
Recruitment Status : Recruiting
First Posted : November 15, 2022
Last Update Posted : June 18, 2023
Information provided by (Responsible Party):
Opus Genetics, Inc

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : August 30, 2024
Estimated Study Completion Date : September 30, 2027